Gestational Hypertension and Preeclampsia: ACOG practice bulletin summary, number 222 published by the American College of Obstetricians and Gynecologists (ACOG). Obstet Gynecol. 2020;135:1492-95.
Li Q, Zhao C, Liu M, Li M, Zhang Y, Yue C. Association between triglyceride-glucose index in early pregnancy and risk of preeclampsia: a multicenter retrospective cohort study. Lipids Health Dis. 2025;24:152.
Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021;4:e218401.
Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76:1690–702.
Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387:999–1011.
Anim-Nyame N, Gamble J, Sooranna SR, Johnson MR, Steer PJ. Relationship between insulin resistance and tissue blood flow in preeclampsia. J Hypertens. 2015;33:1057–63.
Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, et al. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol. 2011;204(327):e321-326.
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-223.
Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178:533–44.
Zeng J, Zhang T, Yang Y, Wang J, Zheng D, Hou Y, et al. Association between a metabolic score for insulin resistance and hypertension: results from National Health and Nutrition Examination Survey 2007–2016 analyses. Front Endocrinol (Lausanne). 2024;15:1369600.
Han KY, Gu J, Wang Z, Liu J, Zou S, Yang CX, et al. Association between METS-IR and prehypertension or hypertension among normoglycemia subjects in Japan: a retrospective study. Front Endocrinol (Lausanne). 2022;13:851338.
Guo Z, Guo X, Xu H, Chu H, Tian Y, Wang S, et al. Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018. Lipids Health Dis. 2025;24:64.
Tsai KZ, Chu CC, Huang WC, Sui X, Lavie CJ, Lin GM. Prediction of various insulin resistance indices for the risk of hypertension among military young adults: the CHIEF cohort study, 2014–2020. Cardiovasc Diabetol. 2024;23:141.
Xu C, Song G, Hu D, Li G, Liu Q, Tang X. Association of METS-IR with incident hypertension in non-overweight adults based on a cohort study in Northeastern China. Eur J Public Health. 2022;32:884–90.
Arabzadeh H, Doosti-Irani A, Kamkari S, Farhadian M, Elyasi E, Mohammadi Y. The maternal factors associated with infant low birth weight: an umbrella review. BMC Pregnancy Childbirth. 2024;24:316.
Swarray-Deen A, Sepenu P, Mensah TE, Osei-Agyapong J, Sefogah PE, Appiah-Sakyi K, et al. Preterm birth in low-middle income countries. Best Pract Res Clin Obstet Gynaecol. 2024;95:102518.
Fitchett EJA, Seale AC, Vergnano S, Sharland M, Heath PT, Saha SK, et al. Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16:e202–13.
GarcÃa-Gómez E, Bobadilla-Bravo M, DÃaz-DÃaz E, Vázquez-MartÃnez ER, Nava-Salazar S, Torres-Ramos Y, et al. High plasmatic levels of advanced glycation end products are associated with metabolic alterations and insulin resistance in preeclamptic women. Curr Mol Med. 2020;20:751–9.
Parretti E, Lapolla A, Dalfrà M, Pacini G, Mari A, Cioni R, et al. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension. 2006;47:449–53.
Cai X, Hu J, Zhu Q, Wang M, Liu S, Dang Y, et al. Relationship of the metabolic score for insulin resistance and the risk of stroke in patients with hypertension: a cohort study. Front Endocrinol (Lausanne). 2022;13:1049211.
Zhang X, Yu C, Ye R, Liu T, Chen X. Correlation between non-insulin-based insulin resistance indexes and the risk of prehypertension: a cross-sectional study. J Clin Hypertens (Greenwich). 2022;24:573–81.
Cheng W, Kong F, Chen S. Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study. Diabetol Metab Syndr. 2022;14:137.
Liu H, Meng C, Wang Z, Liu C, Yu C, Li Z. Association of novel insulin resistance indices with blood pressure in new-onset hypertension and elevated blood pressure individuals: a cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:3953–65.
D’Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, et al. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG. 2006;113:1264–9.
Abhari FR, GhanbariAndarieh M, Farokhfar A, Ahmady S. Estimating rate of insulin resistance in patients with preeclampsia using HOMA-IR index and comparison with nonpreeclampsia pregnant women. Biomed Res Int. 2014;2014:140851.
Schneider S, Freerksen N, Röhrig S, Hoeft B, Maul H. Gestational diabetes and preeclampsia–similar risk factor profiles? Early Hum Dev. 2012;88:179–84.
Hornová M, Šimják P, Anderlová K. Preeclampsia and diabetes mellitus. Cesk Gynekol. 2023;88:467–71.
Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374:434–43.
Balani J, Hyer S, Syngelaki A, Akolekar R, Nicolaides KH, Johnson A, et al. Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin. Obstet Med. 2017;10:170–3.
Ramalingam R, Jha S, Sahu UP, Chaudhary BN, Baxla S, Kumar P. R S, Kumari A: Comparison of Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) and the Level of Cortisol Between Preterm and Term Newborns. Cureus. 2022;14:e32623.
Ahmad A, Rukmini MS, Yadav C, Agarwal A, Manjrekar PA, Hegde A. Indices of glucose homeostasis in cord blood in term and preterm newborns. J Clin Res Pediatr Endocrinol. 2016;8:270–5.
Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H, et al. Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia. 2019;62:2118–28.
Gurza G, MartÃnez-Cruz N, Lizano-Jubert I, Arce-Sánchez L, Suárez-Rico BV, Estrada-Gutierrez G, Montoya-Estrada A, Romo-Yañez J, Solis-Paredes JM, Torres-Torres J, et al. Association of the triglyceride-glucose index during the first trimester of pregnancy with adverse perinatal outcomes. Diagnostics (Basel). 2025;15(9):1129.
Crump C, Sundquist J, Sundquist K. Preterm birth and risk of type 1 and type 2 diabetes: a national cohort study. Diabetologia. 2020;63:508–18.
MarÃn R, Chiarello DI, Abad C, Rojas D, Toledo F, Sobrevia L. Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia. Biochimica et Biophysica Acta (BBA). 2020;1866:165961.
Bahado-Singh RO, Syngelaki A, Mandal R, Graham SF, Akolekar R, Han B, et al. Metabolomic determination of pathogenesis of late-onset preeclampsia. J Matern Fetal Neonatal Med. 2017;30:658–64.
Robillard PY, Dekker G, Scioscia M, Saito S. Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia. Am J Obstet Gynecol. 2022;226:S867-s875.
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco MC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–22.
Scioscia M, Karumanchi SA, Goldman-Wohl D, Robillard PY. Endothelial dysfunction and metabolic syndrome in preeclampsia: an alternative viewpoint. J Reprod Immunol. 2015;108:42–7.
Chen Y, Gao Z, Wang L, Duan R, Hao H, Jia R, et al. The effects of metformin on inflammation and apoptosis in rats with preeclampsia. J Hypertens. 2025;43:255–63.
Sonagra AD, Biradar SM, K D, Murthy DSJ. Normal pregnancy- a state of insulin resistance. J Clin Diagn Res. 2014;8:Cc01–03.
Powe CE, Huston Presley LP, Locascio JJ, Catalano PM. Augmented insulin secretory response in early pregnancy. Diabetologia. 2019;62:1445–52.
Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord. 2013;14:5–12.
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280:E745-751.
Nakanishi N, Shiraishi T, Wada M. Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern Med. 2005;44:542–7.
Ndumele CE, Pradhan AD, Ridker PM. Interrelationships between inflammation, C-reactive protein, and insulin resistance. J Cardiometab Syndr. 2006;1:190–6.
Ding L, Gao YH, Li YR, Huang YF, Wang XY, Qi X. Metabolic score for insulin resistance is correlated to adipokine disorder and inflammatory activity in female knee osteoarthritis patients in a Chinese population. Diabetes Metab Syndr Obes. 2020;13:2109–18.
Yang Y, Wang Y, Lv Y, Ding H. Dissecting the Roles of lipids in preeclampsia. Metabolites. 2022;12(7):590.
Li J, Huang Q, Wang Y, Cui M, Xu K, Suo C, et al. Circulating lipoproteins mediate the association between cardiovascular risk factors and cognitive decline: a community-based cohort study. Phenomics. 2024;4:51–5.
Niu Z, Wu Q, Luo Y, Wang D, Zheng H, Wu Y, et al. Plasma lipidomic subclasses and risk of hypertension in middle-aged and elderly Chinese. Phenomics. 2022;2:283–94.
Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002;287:1420–6.